An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel ...

A BBC health expert has provided an encouraging update on a new drug that has been approved for the treatment of eczema, a debilitating skin condition. The drug, delgocitinib, also known as Anzupgo ...

A recent four-week study found eczema symptoms were no worse for people who bathed daily versus those who bathed once or twice a week. That means people with eczema have the freedom to choose how ...

A BBC health expert has shared a promising update on a new drug that has been approved for the treatment of eczema, a debilitating skin condition, which will help more than 62,000 people in England.

Please provide your email address to receive an email when new articles are posted on . October is Eczema Awareness Month. The National Eczema Association is working to advance key patient priorities, ...

No one should have to suffer from the dry, flaky skin and blisters that are the most common symptoms of eczema, researchers at the Johns Hopkins School of Medicine want Marylanders to know. “Eczema is ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

A groundbreaking technology developed by Heriot-Watt University has received over £475,000 in funding to revolutionize how eczema is diagnosed and treated, potentially ending years of suffering for ...

Dear Dr. Roach: I was diagnosed with stage 4 high-grade ovarian cancer in September 2024. I underwent a major surgery after the tumor shrank in March. I see a top doctor at a renowned hospital, and I ...

Sept 18 (Reuters) - The U.S. Food and Drug Administration has approved Incyte's (INCY.O), opens new tab eczema cream for children aged between 2 and 11 years, the company said on Thursday. Wilmington, ...